I-Sep

Biotechnology
Founded in 2015-01-01
Nantes, Pays de la Loire, France
http://i-sep.com/
For Profit

About I-Sep

i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 2030000 EUR
  • Last Funding: 1230000 EUR (Venture - Series Unknown)
  • Funding Status:

Technology Stack

I-Sep actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Nantes, Pays de la Loire, France